1. Jemal A, Tiwari R, Murray T, et al.: Cancer Statistics, 2004. CA Cancer J Clin 2004, 54:8–29.
2. Brown J, Thorpe H, Napp V, et al.: The big lung trial quality of life study: determining the effect of cisplatin-based chemotherapy for supportive care patients with non-small cell lung cancer. Proc Am Soc Clin Oncol 2003, 22:630a. Confirmed improved quality of life with for cisplatin-based chemotherapy versus supportive care for patients with advanced non-small cell lung cancer.
3. LeChevalier T, Brisgand D, Douillard J, et al.: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994, 12:360.
4. Lilenbaum R, Herndon J, List M, et al.: Single agent versus combination chemotherapy in advanced in advanced non-small cell lung cancer: a CALGB randomized trial of efficacy, quality of life, and cost-effectiveness. Proc Am Soc Clin Oncol 2002, 22:1a.
5. Sederholm C: Gemcitabine compared with gemcitabine plus carboplatin in advanced non-small cell lung cancer: a phase III study by the Swedish Lung Cancer Study Group. Proc Am Soc Clin Oncol 2002, 21:291a.